SEC Form 4 · accession 0001127602-15-006015
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harvey J M D Berger
Officer — Chairman & CEO · Director
Period of report
Feb 11, 2015
Accepted (ET)
Feb 13, 2015 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Feb 11, 2015 | P | 12,500 | $6.7655 | A | 1,851,786 | I | Ocean Capital Partners, Llc |
| Common StockF4,F3 | Feb 12, 2015 | P | 12,500 | $6.9024 | A | 1,864,286 | I | Ocean Capital Partners, Llc |
| Common Stock | holding | — | — | — | 1,250,654 | D | ||
| Common Stock | holding | — | — | — | 246,054 | I | Daughter | |
| Common Stock | holding | — | — | — | 248,745 | I | Daughter | |
| Common Stock | holding | — | — | — | 245,251 | I | Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were aquired pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.73 to $6.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote.
- F3The reporting person is a managing member of this LLC.
- F4The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.84 to $6.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote.